Skip to content
Robots, Ranked.

Are you a robotics manufacturer?

Claim your page to correct your specs and keep your listing current.

1,378companies listed

Robocath

FranceFounded 2009

Ask Scout

Robocath is a robotics company founded 2009, based in France, developing 1 robot primarily in the Surgical / Medical category.

CAPITAL & EVIDENCE

Robocath has no confirmed funding round on file and has 1 cited customer but no deployment on record.

Raised

No confirmed funding round on file

Report a round →

Shipped

1customer cited

named in a public source · no deployment on record

A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Robocath.

In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.

Add a deployment →

Smart robotic solutions for the treatment of cardiovascular diseases

Robocath develops smart robotic platforms for cardiovascular interventions. Key products include R-One, a fully integrated system for remote delivery and adjustment of guidewires and stents during percutaneous coronary intervention (PCI), with CE marking in Europe since 2019, and R-One+, launched in 2023 for coronary angioplasties. Operates in Europe with clinical trials in France for carotid stenting; partnered with MicroPort MedBot for R-ONE approval in China in 2024. Targets interventional cardiologists in hospitals treating cardiovascular diseases.

Company facts

HQ
Rouen, France
Founded
2009 · 17 yrs
Employees
70

RoboScore

Products 65%65Depth 5%0Activity53Attention33Readiness33Evidence 30%50
57.36RoboIndexAll-rounder

57.36 RoboScore + 0.00 Momentum· Strong evidence

Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.

6 of 6 factors known. How it's calculated

Milestones

  1. R-ONE vascular intervention robot received NMPA approval in China via MicroPort MedBot JV

  2. Launched R-One+ robotic platform for coronary angioplasties

  3. Completed CARE clinical trial showing 100% success in robotic carotid stenting

  4. Launched R-One+ robotic platform

  5. R-EVOLUTION clinical study results announced

  6. R-One received CE marking in Europe for cardiovascular treatments

  7. R-One received CE marking approval

  8. 2019partnershipala.associates ↗

    Medical Training and Testing Center in Rouen acquired R-One robot

Press coverage

Public loss record

Noneon file for RobocathRegister read, nothing on file

Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.

How this record was collected, register by register

Active products by Robocath

1 shown
#Category
1
R-OneSurgical / Medical201865.2

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Your request goes to Robocath.

Surgical / Medical buying guides

Industry Knowledge →